medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2018, Number 3

<< Back Next >>

Rev Invest Clin 2018; 70 (3)

Epidemiological Data on the Nutritional Status of Cancer Patients Receiving Treatment with Concomitant Chemoradiotherapy, Radiotherapy or Sequential Chemoradiotherapy to the Abdominopelvic Area

Serralde-Zúñiga A, Castro-Eguiluz D, Aguilar-Ponce JL, Peña-Ruiz AA, Castro-Gutiérrez JV, Rivera-Rivera S, Aranda-Flores C, Casique-Pérez V, Alarcón-Barrios SE, de la Garza-Salazar J, Sánchez-López M, Dueñas-González A

Language: English
References: 31
Page: 117-120
PDF size: 69.37 Kb.


ABSTRACT

Cancer patients are particularly susceptible to undernourishment so associated weight loss is frequent. Approximately 15% of patients lose ›10% of their usual body weight, 40-80% become undernourished, and about 20% die as a result. Well-nourished patients have a higher survival rate when compared with patients at risk of undernourishment (19.9 vs. 3.7 months); hence, nutritional intervention is pivotal. Undernourishment negatively influences the patient’s prognosis, and its prevalence depends on the tumor type and location, disease stage, treatment, and the applied nutritional evaluation tool. During abdominopelvic radiotherapy, up to 90% of patients experience symptoms of varying severity; weight loss during radiotherapy is an early indicator of nutritional deterioration, and he the use of radiation is associated with a higher likelihood of undernourishment. In patients with gynecological malignancies, 12.5-54% are malnourished before receiving oncological treatment, worsening after treatment in 35.8-82% of cases. There is also deterioration of the nutritional status in patients with colorectal cancer once pelvic radiotherapy is initiated, whereby 50% of cases are malnourished at the beginning of treatment, and 66 7% are so when it ends. Although there are notable differences in the impact of radiotherapy on weight according to the radiated region, 88% patients receiving abdominal radiotherapy were found to lose weight compared to 38% of patients whose treatment was limited to the pelvis.


REFERENCES

  1. Huhmann MB, August DA. Review of American society for parenteral and enteral nutrition (ASPEN) clinical guidelines for nutrition support in cancer patients: nutrition screening and assessment. Nutr Clin Pract. 2008;23:182-8.

  2. Tisdale M. Mechanisms of cancer cachexia. Physiol Rev. 2009; 89:381-410.

  3. Isenring E, Cross G, Daniels L, Kellett E, Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer. 2006;14:1152-6.

  4. Wu BW, Yin T, Cao WX, et al. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gastroenterol. 2009;15:3542-9.

  5. Gupta D, Lis CG, Vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer. 2010;18:373-81.

  6. Ramos Chaves M, Boléo-Tomé C, Monteiro-Grillo I, Camilo M, Ravasco P. The diversity of nutritional status in cancer: new insights. Oncologist. 2010;15:523-30.

  7. Kizer NT, Thaker PH, Gao F, et al. The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer. 2011;117:948-56.

  8. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67:257-62.

  9. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a populationbased study. Lancet Oncol. 2008;9:629-35.

  10. Gupta D, Lammersfeld CA, Burrows JL, et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004;80:1634-8.

  11. Nho JH, Kim SR, Kwon YS. Depression and appetite: predictors of malnutrition in gynecologic cancer. Support Care Cancer. 2014;22:3081-8.

  12. Barbosa LR, Lacerda-Filho A, Barbosa LC. Immediate preoperative nutritional status of patients with colorectal cancer: a warning. Arq Gastroenterol. 2014;51:331-6.

  13. Planas M, Peñalva A, Burgos R, et al. Guidelines for colorectal cancer: effects on nutritional intervention. Clin Nutr. 2007;26:691-7.

  14. Khalid U, McGough C, Hackett C, et al. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int J Radiat Oncol Biol Phys. 2006;64:1432-41.

  15. McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer. 2004;90:2278-87.

  16. Hébuterne X, Lemarié E, Michallet M, Montreuil CB De, Schneider SM. Prevalence of malnutrition and current use of nutrition support in patients with cancer. J Parenter Enter Nutr. 2014;38:196-204.

  17. Pezner R, Archambeau J. Critical evaluation of the role of nutritional support with chemotherapy. Cancer. 1985;55:263-7.

  18. Chowdhury Q, Elahi F, Olson AK, Khaled MA. Adjuvant nutritional therapy in the management of malnourished cancer patients. Pakistan J Nutr. 2002;1:119-20.

  19. Orr JW, Wilson K, Bodiford C, et al. Nutritional status of patients with untreated cervical cancer. II. Vitamin assessment. Am J Obstet Gynecol. 1985;151:632-65.

  20. Zorlini R, Cairo AA, Gurgel MS. Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp. 2008;23 577-83.

  21. Santoso JT, Cannada T, O’Farrel B, Alladi K, Coleman RL. Subjective versus objective nutritional assessment study in women with gynecological cancer: a prospective cohort trial. Int J Gynecol Cancer. 2004;14:220-3.

  22. Rodrigues CS, Lacerda MS, Chaves GV. Patient-generated subjective global assessment as a prognosis tool in women with gynecologic cancer. Nutrition. 2015;31:1372-8.

  23. Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007;61:642-6.

  24. Lisboa AQ, Rezende M, Muniz-Junqueira MI, Ito MK. Altered plasma phospholipid fatty acids and nutritional status in patients with uterine cervical cancer. Clin Nutr. 2008;27:371-7.

  25. Hertlein L, Kirschenhofer A, Fürst S, et al. Malnutrition and clinical outcome in gynecologic patients. Eur J Obstet Gynecol Reprod Biol. 2014;174:137-40.

  26. Guren MG, Tobiassen LB, Trygg KU, Drevon C, Dueland S. Dietary intake and nutritional indicators are transiently compromised during radiotherapy for rectal cancer. Eur J Clin Nutr. 2006;60:113-9.

  27. Mahdavi R, Faramarzi E, Mohammad-Zadeh M, Ghaeammaghami J, Jabbari MV. Consequences of radiotherapy on nutritional status, dietary intake, serum zinc and copper levels in patients with gastrointestinal tract and head and neck cancer. Saudi Med J. 2007;28:435-40.

  28. Paixao EM, Gonzalez MC. A prospective study on the radiation therapy associated changes in body weight and bioelectrical standardized phase angle. Clin Nutr. 2015;34:496-500.

  29. Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18:987-94.

  30. Olopade FA, Norman A, Blake P, et al. A modified inflammatory bowel disease questionnaire and the vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer. 2005;92:1663-70.

  31. Andreyev HJ, Davidson SE, Gillespie C, Allum WH, Swarbrick E. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61:179-92.




2020     |     www.medigraphic.com